Trade XFOR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
X4 Pharmaceuticals, Inc. (XFOR) is trading at US$4.17, down 1.35% today as of Aug 28, 09:40 EDT. The company has a market capitalisation of US$400.55M. Over the past 52 weeks, XFOR has traded between US$2.80 and US$4.83. On Syfe you can trade XFOR with $0 commission and add it to your watchlist.
| Previous close | US$4.23 |
|---|---|
| Market cap | US$400.55M |
| 52-week range | US$2.80 – US$4.83 |
| Volume | 597.23K |
| Exchange | US |
Add to Watchlist
Set Price Alert
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Year: 2017
--Wells Fargo Initiates Coverage on X4 Pharmaceuticals With Overweight Rating
Jul 10, 11:54 AM · MT Newswires
--Leerink Partners Initiates X4 Pharmaceuticals at Outperform With $12 Price Target
Jun 2, 10:25 AM · MT Newswires
X4 Pharmaceuticals, Inc. (XFOR) stock is trading at US$4.17, -1.35% from the previous close of US$4.23.
The market cap for X4 Pharmaceuticals, Inc. (XFOR) stock is approximately US$400.55M.
The 52-week high for X4 Pharmaceuticals, Inc. (XFOR) stock is US$4.83.
The 52-week low for X4 Pharmaceuticals, Inc. (XFOR) stock is US$2.80.
X4 Pharmaceuticals, Inc. (XFOR) does not currently pay a dividend.
Stay on top of XFOR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
